Journal article
Tenecteplase versus alteplase before endovascular thrombectomy (EXTEND-IA TNK): A multicenter, randomized, controlled study
BCV Campbell, PJ Mitchell, L Churilov, N Yassi, TJ Kleinig, B Yan, RJ Dowling, SJ Bush, HM Dewey, V Thijs, M Simpson, M Brooks, H Asadi, TY Wu, DG Shah, T Wijeratne, T Ang, F Miteff, C Levi, M Krause Show all
International Journal of Stroke | SAGE PUBLICATIONS LTD | Published : 2018
Abstract
Background and hypothesis: Intravenous thrombolysis with alteplase remains standard care prior to thrombectomy for eligible patients within 4.5 h of ischemic stroke onset. However, alteplase only succeeds in reperfusing large vessel arterial occlusion prior to thrombectomy in a minority of patients. We hypothesized that tenecteplase is non-inferior to alteplase in achieving reperfusion at initial angiogram, when administered within 4.5 h of ischemic stroke onset, in patients planned to undergo endovascular therapy. Study design: EXTEND-IA TNK is an investigator-initiated, phase II, multicenter, prospective, randomized, open-label, blinded-endpoint non-inferiority study. Eligibility requires ..
View full abstractGrants
Awarded by Stroke Foundation
Funding Acknowledgements
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Campbell reports research support from the National Health and Medical Research Council of Australia (GNT1043242, GNT1035688 GNT1113352, GNT1111972), Royal Australasian College of Physicians, Royal Melbourne Hospital Foundation, National Heart Foundation, Stroke Foundation of Australia.